Quick answer
What is Pinealon?
Built from index records dated 2026-10-09 to 2026-10-13 Compiled by an automated pipeline, checked by The Peptide Observer editorial desk. No qualified clinical reviewer. How this site works
Pinealon is a peptide, grouped on this site under Short peptide bioregulators, and the 12 research records kept here are 5 from studies in rats or mice, 1 from a trial in people and 6 that do not state what kind of study it is.
The literature search returned 17 records. This site keeps 12 of them, which is 71 per cent of what came back.
What it is
This site puts it in the Short peptide bioregulators group.
A tripeptide bioregulator; the retrieved records report an interaction with DNA and suppression of free radical levels in cells, with no receptor target named.[1, 2]
Stated in the titles of the cited 2019 Journal of Physical Chemistry B and 2011 Rejuvenation Research papers.
What kind of records
A small number of the records kept here are trials in people.
That sentence is produced by counting, not by reading. What was counted: 1 interventional human trial record among 12 indexed records.
What this does not settle
- What it does in a body. Counting records is not reading them, and nothing here has been read in full.
- Whether it causes harm. No adverse-effect row was taken from any source for this entry.
- How long it lasts. No pharmacokinetics source was retrieved for this entry.
- What the other 5 retrieved records say. They are not in this index.
The longer explanation
Where this comes from
The records cited above, in full.
- Role of Mono- and Divalent Ions in Peptide Glu-Asp-Arg-DNA Interaction. The journal of physical chemistry. B (2019). pmid:30762356
- Pinealon increases cell viability by suppression of free radical levels and activating proliferative processes. Rejuvenation research (2011). pmid:21978084